8
P. M. BOGIE ET AL.
DMSO-d6) δ 158.8, 143.2, 140.8, 140.0, 138.4, 136.7, 130.1,
128.7, 127.2, 126.4, 125.4, 124.5, 121.1, 98.4, 85.2.
6H), 1.55 (s, 6H). 13C NMR: (125 MHz, CDCl3) δ 172.0, 156.1,
154.2, 140.1, 134.3, 128.1, 123.6, 120.5, 116.7, 116.3, 98.0,
47.3, 45.8, 37.7, 26.7. HRMS (ESI-) calc. C31H28N6, 484.2375;
found, 529.2357 (M + HCOO)−.
3.1.2.6. 9,9-dimethyl-9H-fluorene(20). Fluorene, (1 g,
6.01 mmol) was placed in a Schlenk flask along with 3 eq
potassium tert-butoxide (2.02 g, 18.05 mmol). The flask
was purged with N2 followed by the addition of 30 mL THF.
The orange solution was stirred for 10 min. Iodomethane
(1.12 mL, 18.05 mmol) was added slowly to the flask over a
period of 10 min. The reaction was heated at 65 °C for 16 h
then cooled, diluted with 100 mL ice water and extracted
with DCM. The organic layer was washed with brine and
saturated sodium bicarbonate (30 mL each), dried with
magnesium sulphate, and the solvent removed in vacuo to
afford yellow waxy solid (1.074 g, 5.53 mmol, 92%). 1H NMR
spectra were in agreement with previously reported results.
3.1.2.10. 9,9-dimethyl-9H-fluorene-1,1′-di-(1-Hydroxy-
2-imino-4-phenyl-1,2-dihydro-pyridine-3-carbonitrile)
(Ligand 2).
Synthesised from 8 using the same
procedure reported for Compound 7. Isolated as a tan
1
powder (1.080 g, 2.33 mmol, 92%). H NMR: (500 MHz,
DMSO-d6) δ 8.44 (d, J = 6.7 Hz, 2H), 8.07 (d, J = 7.9 Hz,
2H), 7.89 (s, 2H), 7.82 (s, 4H), 7.65 (d, J = 8.1 Hz, 2H),
6.91 (d, J = 6.7 Hz, 2H), 1.54 (s, 6H). 13C NMR: (125 MHz,
DMSO-d6) δ 154.6, 153.2, 143.0, 140.4, 139.4, 135.6, 128.1,
123.6, 121.5, 115.6, 112.9, 90.2, 47.5, 26.8. HRMS (ESI-
) calc. C27H20N6O2, 460.1648; found, 459.1575 (M−H)−.
Purified and isolated as the HCl salt. Elemental Analysis:
Theoretical (C27H20ClN6O2): C: 65.52, H: 4.45, Cl: 7.12, N:
16.88, O: 6.03. Found: C: 66.86, H: 4.69, N: 17.03, O: 6.30.
3.1.2.7. 1,
1-(7-Acetyl-9,9-dimethyl-9H-fluoren-2-yl)-
ethanone (21). Acetyl chloride (1.83 mL, 25.74 mmol)
was dissolved in 50 mL dichloromethane in a round-
bottomed flask. Aluminium chloride (3.43 g, 25.74 mmol)
was added and the flask placed in an ice bath with stirring.
Dimethyl fluorene (1 g, 5.15 mmol) was dissolved in 5 mL
DCM and added dropwise to the cooled flask over 5 min.
The flask was removed from the ice bath and heated to
reflux for 2.5 h or until complete via TLC analysis. Once
complete, the reaction mixture was poured over 150 g
of ice and extracted with DCM. The organic layer was
washed with brine (2 × 50 mL) and saturated sodium
bicarbonate (2 × 50 mL), dried over magnesium sulphate,
and the solvent removed in vacuo to give a tan crystalline
3.1.2.11. Anionic Ligand 2 (Na42). Anionic Ligand
2 was synthesised using the procedure reported for
Anionic Ligand 1. Isolated as a dark brown powder
1
(33 mg, 0.06 mmol, yield = 56%). H NMR: (500 MHz,
DMSO-d6) δ 7.93 (d, J = 7.8 Hz, 2 H), 7.75 (d, J = 6.2 Hz, 4H),
7.72 (s, 2H), 7.53 (d, J = 7.8 Hz, 2H), 5.59 (d, J = 6.3 Hz, 2H),
1.53 (s, 6H). 13C NMR: (125 MHz, DMSO-d6) δ 156.5, 154.3,
143.5, 138.9, 138.3, 137.2, 127.7, 123.2, 120.9, 118.9, 104.7,
87.42, 55.4, 47.3, 27.0.
3.1.2.12. 1-Hydroxy-2-imino-4-phenyl-1,2-dihydro-
1
solid (1.120 g, 4.02 mmol, 78%). H NMR spectra were in
pyridine-3-carbonitrile
(3). (3-(dimethylamino)-
agreement with previously reported results.
1-phenyl-2-propenylidene) malononitrile (332 mg,
1.44 mmol) was dissolved in anhydrous DCM (3 mL). To the
solution was added hydroxylamine hydrochloride (484 mg,
4.33 mmol) and trimethylamine (970 μL, 4.33 mmol). The
mixture was allowed to stir for 24 h, then reduced under
vacuum.The solid was then sonicated in water and isolated
via vacuum filtration to afford a yellow powder (128 mg,
3.1.2.8. 2-Cyano-3-[7-(2,2-dicyano-1-methyl-vinyl)-
9,9-dimethyl-9H-fluoren-2-yl]-but-2-enenitrile
Synthesised from 1,1′-diacetyl-9,9-dimethyl-9H-fluorene
using the same procedure reported for 5. Isolated as
an orange powder (984 mg, 2.63 mmol, 80%). H NMR:
(500 MHz, CDCl3) δ 7.87 (d, J = 7.9 Hz, 2H), 7.70 (s, 2H),
7.59 (d, J = 7.2 Hz, 2H), 2.71 (s, 6H), 1.56 (s, 6H). C NMR:
(125 MHz, CDCl3) δ 175.0, 154.9, 141.7, 135.8, 127.1, 122.3,
121.4, 113.1, 112.8, 84.4, 47.7, 26.5, 24.2. HRMS (ESI-) calc.
C25H18N4, 374.1531; found, 373.1459 (M−H)−.
(7).
1
1
0.60 mmol, 42%). H NMR: (500 MHz, DMSO-d6) δ 8.41 (d,
13
J = 6.7 Hz, 1H), 7.80 (s, 2H), 7.60 (d, J = 7.3 Hz, 2H), 7.52 (p,
J = 6.2 Hz, 3H), 6.78 (d, J = 6.7 Hz, 1H). 13C NMR: (125 MHz,
DMSO-d6) δ 153.1, 142.8, 140.4, 140.3, 136.2, 129.9, 129.2,
128.7, 115.4, 112.8, 112.8, 90.3. HRMS (ESI-) calc. C12H9N3O,
211.0746; found, 210.0673 (M – H)−. Elemental Analysis:
Theoretical (C12H9N3O): C: 68.24, H: 4.29, N: 19.89, O: 7.57.
Found: C: 68.31, H: 4.33, N: 20.08, O: 7.28.
3 . 1 . 2 . 9 . 2 - C y a n o - 3 - { 7 - [ 2 , 2 - d i c y a n o - 1 - ( 2 -
dimethylamino-vinyl)-vinyl]-9,9-dimethyl-9H-fluoren-
2-yl}-5-dimethylamino-allylidene)-malononitrile
(8). Synthesised from 7 using the same procedure
reported for 6, isolated as an orange waxy solid (1.033 g,
3.1.2.13. Anionic Ligand 3 (Na23). Synthesised from
3 using the procedure reported for Anionic Ligand 1
1
1
2.13 mmol, 83%). H NMR: (500 MHz, CDCl3) δ 7.81 (d,
(yield = 26 mg, 0.101 mmol, 43%). H NMR: (500 MHz,
J = 7.8 Hz, 2H), 7.39 (s, 2H), 7.27 (t, J = 8.8 Hz, 2H), 6.73 (d,
J = 12.4 Hz, 2H), 5.87 (d, J = 12.4 Hz, 2H), 3.06 (s, 6H), 3.05 (s,
DMSO-d6) δ 7.72 (d, J = 6.3 Hz, 1H), 7.50 (d, J = 7.4 Hz, 2H),
7.45 (t, J = 7.5 Hz, 2H), 7.40 (t, J = 6.9 Hz, 1H), 6.61 (s, 1H), 5.45